15-99729449-C-G
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_001284417.2(LYSMD4):āc.565G>Cā(p.Glu189Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000545 in 1,614,188 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001284417.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LYSMD4 | NM_001284417.2 | c.565G>C | p.Glu189Gln | missense_variant | 3/3 | ENST00000684762.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LYSMD4 | ENST00000684762.1 | c.565G>C | p.Glu189Gln | missense_variant | 3/3 | NM_001284417.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000427 AC: 65AN: 152224Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000628 AC: 158AN: 251420Hom.: 1 AF XY: 0.000743 AC XY: 101AN XY: 135880
GnomAD4 exome AF: 0.000558 AC: 815AN: 1461846Hom.: 9 Cov.: 77 AF XY: 0.000590 AC XY: 429AN XY: 727226
GnomAD4 genome AF: 0.000427 AC: 65AN: 152342Hom.: 0 Cov.: 33 AF XY: 0.000430 AC XY: 32AN XY: 74502
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 23, 2021 | The c.568G>C (p.E190Q) alteration is located in exon 6 (coding exon 4) of the LYSMD4 gene. This alteration results from a G to C substitution at nucleotide position 568, causing the glutamic acid (E) at amino acid position 190 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at